stoxline Quote Chart Rank Option Currency Glossary
  
(AVDS)
  0 (0%)    04-29 17:04
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-04-29 4:44:16 PM
Short term     
Mid term     
Targets 6-month :  61.23 1-year :  62.31
Resists First :  52.42 Second :  53.34
Pivot price 52.29
Supports First :  50.93 Second :  42.38
MAs MA(5) :  51.19 MA(20) :  52.44
MA(100) :  51 MA(250) :  0
MACD MACD :  -0.3 Signal :  0
%K %D K(14,3) :  5.2 D(3) :  4.4
RSI RSI(14): 36
52-week High :  53.34 Low :  43.93
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ AVDS ] has closed above bottom band by 11.9%. Bollinger Bands are 60.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 51.14 - 51.43 51.43 - 51.74
Low: 50.12 - 50.44 50.44 - 50.8
Close: 50.39 - 50.95 50.95 - 51.57
Company Description

Headline News

Sat, 16 Mar 2024
American Vanguard (NYSE:AVD) Is Due To Pay A Dividend Of $0.03 - Simply Wall St

Fri, 15 Mar 2024
American Vanguard (AVD) Q4 Earnings Meet, Sales Miss Estimates - Zacks Investment Research

Sun, 10 Mar 2024
Should You Think About Buying American Vanguard Corporation (NYSE:AVD) Now? - Yahoo Finance

Wed, 14 Feb 2024
10 Cool Vendors For AVD, Virtual Desktop Solution Providers - CRN

Sat, 03 Feb 2024
Angiogenesis 2024: AVD-104 for Geographic Atrophy - Ophthalmology Times

Tue, 16 Jan 2024
Aviceda Therapeutics Announces Topline Data from Part 1 of the Phase 2/3 SIGLEC Clinical Trial for AVD-104 ... - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android